Foster common approaches between People’s Republic of China and the European Union on Personalised Medicine research, development, innovation and policies
News
IC2PerMed Exploitation Workshop in Nice on 12-13 July 2023
On July 12th and 13th 2023 the IC2PerMed Consortium will meet in Nice to discuss and plan [...]
New deliverables online
We are glad to inform you that three of IC2PerMed's public reports are now available! These reports [...]
Why Do We Need Personalised Medicine in Cancer? The Case of The EU and China
Participation is FREE. Register to save Your Spot ! Cancer is a devastating disease that kills hundreds [...]
IC2PerMed at a glance
Supporting International collaboration for the development of Personalised Medicine
The International Consortium for Personalised Medicine (ICPerMed), umbrella initiative of IC2PerMed, aims at initiating and supporting communication and exchange on Personalised Medicine (PM) for aligning national agendas on research and funding activities. It brings together representatives of funding agencies and authorities from 29 countries and expands for increasing PM developments’ synergies at international level.
IC2PerMed project’s core objective is to build upon collaborative developments of Chinese and European experts on PM for elaborating a common strategy, enabling Chinese institutions to join the ICPerMed consortium. The 3 Expert Working Groups will set the path for a common approach of PM research, innovation, development and implementation over the project duration.
